Dafna D Gladman, MD, FRCPC

Senior Scientist, Krembil Research Institute (Krembil)
*This is not a trusted UHN email destination.
https://orcid.org/0000-0002-9074-0592
Keywords: psoriatic arthritis, systemic lupus erythematosus (SLE), rheumatoid arthritis
Prognosis, genetic and theraupeutic studies in the rheumatic diseases particularly:
  • Psoriatic arthritis
  • Systemic lupus erythematosus
  • Rheumatoid arthritis

Related Links

Associated Program(s)
Use of combined hormonal contraceptives among women with systemic lupus erythematosus with and without medical contraindications to oestrogen.
Rheumatology (Oxford). 2019 Feb 08;:
Mendel A, Bernatsky S, Pineau CA, St-Pierre Y, Hanly JG, Urowitz MB, Clarke AE, Romero-Diaz J, Gordon C, Bae SC, Wallace DJ, Merrill JT, Buyon J, Isenberg DA, Rahman A, Ginzler EM, Petri M, Dooley MA, Fortin P, Gladman DD, Steinsson K, Ramsey-Goldman R...
Etanercept and Methotrexate as Monotherapy or in Combination for Psoriatic Arthritis: Primary Results From a Randomized, Controlled Phase 3 Trial.
Arthritis Rheumatol. 2019 Feb 12;:
Mease PJ, Gladman DD, Collier DH, Ritchlin CT, Helliwell PS, Liu L, Kricorian G, Chung JB
Effect of tofacitinib on patient-reported outcomes in patients with active psoriatic arthritis and an inadequate response to tumour necrosis factor inhibitors in the phase III, randomised controlled trial: OPAL Beyond.
RMD Open. 2019;5(1):e000808
Strand V, de Vlam K, Covarrubias-Cobos JA, Mease PJ, Gladman DD, Chen L, Kudlacz E, Wu J, Cappelleri JC, Hendrikx T, Hsu MA
Tofacitinib or adalimumab versus placebo: patient-reported outcomes from OPAL Broaden-a phase III study of active psoriatic arthritis in patients with an inadequate response to conventional synthetic disease-modifying antirheumatic drugs.
RMD Open. 2019;5(1):e000806
Strand V, de Vlam K, Covarrubias-Cobos JA, Mease PJ, Gladman DD, Graham D, Wang C, Cappelleri JC, Hendrikx T, Hsu MA
Predicting adherence to therapy in rheumatoid arthritis, psoriatic arthritis or ankylosing spondylitis: a large cross-sectional study.
RMD Open. 2019;5(1):e000585
Smolen JS, Gladman D, McNeil HP, Mease PJ, Sieper J, Hojnik M, Nurwakagari P, Weinman J
Atherosclerotic Vascular Events in Systemic Lupus Erythematosus - an Evolving Story.
J Rheumatol. 2019 Feb 01;:
Urowitz MB, Su J, Gladman DD
Ixekizumab and complete resolution of enthesitis and dactylitis: integrated analysis of two phase 3 randomized trials in psoriatic arthritis.
Arthritis Res Ther. 2019 Jan 29;21(1):38
Gladman DD, Orbai AM, Klitz U, Wei JC, Gallo G, Birt J, Rathmann S, Shrom D, Marzo-Ortega H
Osteopontin and Disease Activity in Patients with Recent-onset Systemic Lupus Erythematosus: Results from the SLICC Inception Cohort.
J Rheumatol. 2019 Jan 15;:
Wirestam L, Enocsson H, Skogh T, Padyukov L, Jönsen A, Urowitz MB, Gladman DD, Romero-Diaz J, Bae SC, Fortin PR, Sanchez-Guerrero J, Clarke AE, Bernatsky S, Gordon C, Hanly JG, Wallace D, Isenberg DA, Rahman A, Merrill J, Ginzler E, Alarcón GS, Chatham...
Correction to: The association between sonographic enthesitis and radiographic damage in psoriatic arthritis.
Arthritis Res Ther. 2019 Jan 14;21(1):20
Polachek A, Cook R, Chandran V, Gladman DD, Eder L
Low aspirin use and high prevalence of pre-eclampsia risk factors among pregnant women in a multinational SLE inception cohort.
Ann Rheum Dis. 2018 Dec 20;:
Mendel A, Bernatsky SB, Hanly JG, Urowitz MB, Clarke AE, Romero-Diaz J, Gordon C, Bae SC, Wallace DJ, Merrill JT, Buyon JP, Isenberg DA, Rahman A, Ginzler EM, Petri M, Dooley MA, Fortin PR, Gladman DD, Steinsson K, Ramsey-Goldman R, Khamashta MA,...

Pages


 
Senior Scientist, Krembil Research Institute (Krembil)

Deputy Director, Centre for Prognosis Studies in the Rheumatic Diseases (part of the UHN Arthritis and Autoimmunity Research Centre)
Co-Director, Lupus Clinic, Toronto Western Hospital (TWH)
Director, Psoriatic Arthritis Program, TWH